Elecsys® Troponin T Gen 5

Enabling fast diagnosis of acute myocardial infarction
Roche Troponin T-high sensitive (cTnT-hs)
Make a difference when every minute counts

In the case of suspected AMI, prompt treatment is essential. Patients with NSTEMI who had other initial diagnoses had a significant 14% reduction in their time to death.1

High-sensitivity cardiac troponins are the preferred standards for establishing a biomarker diagnosis of AMI, allowing for more accurate detection and exclusion of myocardial injury according to the 2021 AHA/ACC Chest Pain Guidelines.2 Troponin is the gold standard to distinguish between AMI and non-AMI patients.3-4

Accurate diagnosis of Acute Myocardial Infarction (AMI) is often difficult and time-consuming.

Early diagnosis is critical, as every 30-minute delay between symptoms and treatment increases the 1-year mortality rate by 7.5%.1 

Elecsys® Troponin T Gen 5, an assay that aids in the diagnosis of myocardial infarction, is able to provide confidence to rule-in and rule-out patients, when results are crucial for decision-making.5

Speed
Elecsys® Troponin T Gen 5 provides the fastest troponin turnaround time of all highly sensitive assays.
 
  • Delivering results in 9 minutes, Elecsys® Troponin T Gen 5 helps speed decision-making.
  • Faster results help clinicians start treatment sooner and potentially helps save heart function.
Sensitivity
Bring new confidence to cardiac care
 

Elecsys® Troponin T Gen 5 is the first FDA-cleared troponin assay to meet the IFCC recommendations for high sensitivity AND deliver optimal precision per the Fourth Universal Definition of Myocardial Infarction.4

Assay specifications

  • Assay time

    9 minute STAT assay

  • 99th percentile upper reference limit

    14 ng/L (pg/mL) for females, 22 ng/L (pg/mL) for males

  • 10% CV precision

    13 ng/L (pg/mL)

  • Sample material

    lithium-heparin, plasma

Would you like to know more about the Elecsys® Troponin T Gen 5 test?

Please submit your information in the following form to be contacted by a Roche representative with more details.

Support

Support

Comprehensive Support Helps Simplify Adoption

With Elecsys® TnT Gen 5, you’re backed by the most comprehensive educational offering in the industry.

Leverage Our Clinical Specialists

Learn about evidence-based best practices and current care guidelines from cardiac subject matter experts.

Roche Support Network (RSN)

Receive dedicated before-and-after sales support from our highly experienced, specialized teams.

Abbreviations

NSTEMI: non–ST-segment elevation myocardial infarction


References

  1. De Luca, et al. Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction. Circulation. 2004;109(10):1223-1225..
  2. Gulati M, et al. Guideline for the Evaluation and Diagnosis of Chest Pain. J Am Coll Cardiol. 2021 Nov 30;78(22):e187-e285.
  3. Collet JP, et al. Eur Heart J. 2021;42(14):1289-1367.
  4. Thygesen K, et al. Eur Heart J. 2019;40, 237–269.
  5. Elecsys® Troponin T Gen 5 and Troponin T Gen 5 STAT method sheets.
...
    ...